The Global Standard Insulin Pen Needles Market was valued at USD 1.66 billion in 2023 and is projected to reach USD 2.52 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period (2023-2032). This expansion reflects the increasing global diabetes prevalence, wider adoption of insulin therapy, and technological advancements enhancing injection comfort and safety.
As patient-centric diabetes care becomes the norm, manufacturers are prioritizing needle designs that combine precision with minimal discomfort. Here we analyze the Top 10 Companies in the Standard Insulin Pen Needles Market—established medical technology leaders and specialized manufacturers setting new benchmarks in subcutaneous drug delivery.
🔟 1. Becton, Dickinson and Company (BD)
Headquarters: Franklin Lakes, New Jersey, USA
Key Products: BD Ultra-Fine™ Nano, BD AutoShield Duo
BD dominates the insulin needle sector with patented thin-wall technology enabling its industry-leading 32G ultra-fine needles. The company’s R&D focuses on pain reduction and injection site safety across all patient demographics.
Technological Advantages:
- Thinest-wall 32G needles with enhanced flexibility
- Integrated safety mechanisms preventing needlestick injuries
- Universal compatibility with major insulin pen brands
Download FREE Sample Report: Standard Insulin Pen Needles Market – Comprehensive Research Analysis
9️⃣ 2. Novo Nordisk A/S
Headquarters: Bagsværd, Denmark
Key Products: NovoFine® Plus, NovoTwist®
This diabetes care leader manufactures needles optimized for its proprietary insulin pens while maintaining cross-brand compatibility. Recent innovations focus on reducing injection force for patients with manual dexterity challenges.
Technological Advantages:
- Proprietary lubrication for smoother skin penetration
- Ergonomic designs for elderly and pediatric patients
- Color-coded size identification system
8️⃣ 3. Artsana Group (Pediatric)
Headquarters: Grandate, Italy
Key Product: ComforTwist® Safety Pen Needles
Artsana’s Pediatric division specializes in safety-engineered needles featuring innovative passive shielding mechanisms that automatically activate post-injection.
Technological Advantages:
- Audible-click safety confirmation
- 360° rotating sleeve for optimal injection angles
- Reduced penetration force requiring less pressure
7️⃣ 4. B. Braun Melsungen AG
Headquarters: Melsungen, Germany
Key Product: SteriClic Safety Pen Needles
B. Braun’s safety needles feature a unique double-shield system protecting patients and healthcare providers throughout the injection process and disposal.
Technological Advantages:
- Dual-point needle stabilization technology
- Consistent insulin flow rate across needle gauges
- Low-waste manufacturing processes
Download FREE Sample Report: Standard Insulin Pen Needles Market – Comprehensive Research Analysis
6️⃣ 5. Terumo Corporation
Headquarters: Tokyo, Japan
Key Product: SurGuard® Safety Pen Needles
Terumo applies Japanese micro-engineering to produce some of the sharpest pen needles, with silicon coatings that reduce tissue resistance during injection.
Technological Advantages:
- Micro-laser cut needle bevels for precise penetration
- Consistent wall thickness along needle length
- Anti-coring design prevents rubber particle contamination
5️⃣ 6. Ypsomed Holding AG
Headquarters: Burgdorf, Switzerland
Key Product: Clickfine® Pen Needles
Specializing in injection systems, Ypsomed develops pen needles featuring advanced connector technology that ensures leak-proof insulin pen attachments.
Technological Advantages:
- Patented click-on attachment mechanism
- Precision inner bore geometry
- Swiss-made ultra-thin stainless steel
4️⃣ 7. Owen Mumford Ltd
Headquarters: Woodstock, UK
Key Product: Unifine® Pentips®
This British manufacturer focuses on accessibility features, with needle designs accommodating vision-impaired and dexterity-challenged patients.
Technological Advantages:
- High-contrast visual indicators
- Increased surface grip areas
- Tactile feedback during injection
3️⃣ 8. HTL-Strefa S.A.
Headquarters: Łódź, Poland
Key Product: Pikdare® Pen Needles
As Europe’s largest needle producer, HTL-Strefa combines precision manufacturing with cost optimization, making quality needles accessible in emerging markets.
Technological Advantages:
- Multi-stage laser inspection systems
- Automated quality control protocols
- Broad hospital-grade product range
2️⃣ 9. Allison Medical, Inc.
Headquarters: Spokane, Washington, USA
Key Product: MicroFine® Pen Needles
Allison Medical specializes in ultra-fine needles (up to 34G) that maintain structural integrity while minimizing patient discomfort.
Technological Advantages:
- Precision electrochemical polishing
- Laser-bore technology for consistent diameters
- Rx-specific needle length configurations
1️⃣ 10. UltiMed, Inc.
Headquarters: Plymouth, Minnesota, USA
Key Product: Ulti-Care Pen Needles
UltiMed focuses on value-engineered solutions that maintain clinical performance while optimizing manufacturing efficiencies.
Technological Advantages:
- High-precision grinding technology
- Automated assembly for consistent quality
- Cost-efficient single-unit packaging
Get Full Report: Standard Insulin Pen Needles Market – Complete Industry Analysis
🌍 Market Outlook: Evolving Standards in Insulin Delivery
The insulin pen needle sector is undergoing rapid transformation, driven by patient needs for comfort and healthcare system demands for cost-effective solutions.
📈 Key Industry Developments:
- Accelerating shift toward shorter (4mm-6mm) needles suitable for all patient types
- Growing emphasis on safety-engineered designs to meet regulatory requirements
- Increasing integration of smart technologies for dose tracking and adherence
- Expansion in emerging markets with rising diabetes diagnosis rates
- Development of eco-friendly materials and recyclable components
Market Segmentation Analysis
By Needle Length:
- 4mm: Fastest-growing segment (37% of market) with 5.8% CAGR
- 5mm: Established standard length (28% market share)
- 6mm+: Declining use (35%) except for specific clinical needs
By Application:
- Home Care: 68% of total market volume
- Clinical Settings: 27% including hospitals and long-term care
- Other Uses: 5% including specialized applications
Regional Market Performance:
- North America: Mature market (USD 469M) with high safety adoption
- Europe: Growth driven by aging populations and reimbursement policies
- Asia-Pacific: Expansion hotspot (6.1% CAGR) with rising diabetes rates
- Latin America: Emerging opportunities in Brazil and Mexico
Download FREE Sample Report: Standard Insulin Pen Needles Market – Comprehensive Research Analysis
The companies profiled represent the vanguard of injection technology innovation, demonstrating how medical device engineering continues to improve diabetes management worldwide.